Skip to main content
Log in

Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Background

Xanthelasma palpebrarum (XP) is associated with increased risk of ischemic heart disease and myocardial infarction independent of other well-known cardiovascular risk factors. Cardio-ankle vascular index (CAVI) is a novel index of arterial stiffness and important marker of subclinical atherosclerosis. The purpose of this study was to investigate the association between XP and CAVI in asymptomatic subjects.

Methods

Consecutive 50 subjects with XP and age-gender matched 50 control subjects were enrolled. Patients with known atherosclerotic vascular disease were excluded. Arterial stiffness was assessed by CAVI and defined as abnormal if CAVI is ≥ 8.

Results

Subjects with XP had higher mean CAVI than control subjects (8.05 ± 1.72 vs. 6.76 ± 1.18, p < 0.001). Frequency of abnormal CAVI was higher in subjects with XP (n = 27) compared to those without XP (n = 9, 54 vs. 18 %, p < 0.001). There was a significant correlation between XP and CAVI (r = 0.42, p < 0.001). Conditional logistic regression analysis showed that XP (odds ratio OR 8.80, 95 % confidence interval CI 2.63–29.49, p < 0.001) and age (OR 1.17, 95 % CI 1.08–1.26, p < 0.001) were independent predictors for abnormal CAVI.

Conclusion

The study suggests that XP is associated with increased arterial stiffness in asymptomatic subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497. doi:10.1136/bmj.d5497.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Pandhi D, Gupta P, Singal A, et al. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J. 2012;88:198–204.

    Article  PubMed  Google Scholar 

  3. Akyüz AR, Ağaç MT, Turan T, et al. Xanthelasma is associated with increased amount of epicardial adipose tissue. Med Princ Pract. 2016;25(2):187–90. doi:10.1159/000441846.

    Article  PubMed  Google Scholar 

  4. Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study. Circulation. 2014;129(9):990–8.

    Article  PubMed  Google Scholar 

  5. Bergman R. Xanthelasma palpebrarum and risk of atherosclerosis. Int J Dermatol. 1998;37(5):343–5.

    Article  CAS  PubMed  Google Scholar 

  6. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.

    Article  PubMed  Google Scholar 

  7. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.

    Article  CAS  PubMed  Google Scholar 

  8. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–7.

    Article  CAS  PubMed  Google Scholar 

  9. Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004;27(9):625–31.

    Article  PubMed  Google Scholar 

  10. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.

    Article  CAS  PubMed  Google Scholar 

  11. Korkmaz L, Erkan H, Korkmaz AA, et al. Relationship of aortic knob width with cardio-ankle vascular stiffness index and its value in diagnosis of subclinical atherosclerosis in hypertensive patients: a study on diagnostic accuracy. Anadolu Kardiyol Derg. 2012;12(2):102–6.

    PubMed  Google Scholar 

  12. Kanamoto M, Matsumoto N, Shiga T, et al. Relationship between coronary artery stenosis and cardio-ankle vascular index (CAVI) in patients undergoing cardiovascular surgery. J Cardiovasc Dis Res. 2013;4(1):15–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Park JB, Park HE, Choi SY, et al. Relation between Cardio-Ankle Vascular Index and Coronary Artery Calcification or Stenosis in Asymptomatic Subjects. J Atheroscler Thromb. 2013;20(6):557–67.

    Article  PubMed  Google Scholar 

  14. Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res. 2007;30:335–40.

    Article  PubMed  Google Scholar 

  15. Nakamura K, Tomaru T, Yamamura S, et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J. 2008;72(4):598–604.

    Article  PubMed  Google Scholar 

  16. Sekikawa A, Shin C, Curb JD, et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis. 2012;222(2):473–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. VaSera VS-1000 operation manual, Fukuhada Denshi CO., LTD, Tokyo, JAPAN. tp://www.fukuda.co.jp/english/products/special_features/vasera/cavi.html.

  18. Park HE, Choi SY, Kim MK, et al. Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography. J Cardiol. 2012;60(5):372–6.

    Article  PubMed  Google Scholar 

  19. Agac MT, Bektas H, Korkmaz L, et al. Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults. J Eur Acad Dermatol Venereol. 2015;29(1):26–30.

    Article  CAS  PubMed  Google Scholar 

  20. Jain A, Goyal P, Nigam PK, et al. Xanthelasma palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi. Indian J Clin Biochem. 2007;22(2):151–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Segal P, Insull W Jr, Chambless LE, et al. The association of dyslipoproteinemia with corneal arcus and xanthelasma: the Lipid Research Clinics Program Prevalence Study. Circulation. 1986;73:I108–18.

    Article  CAS  PubMed  Google Scholar 

  22. Parker F, Odland GF. Experimental xanthoma: a correlative biochemical, histologic, histochemical, and electron microscopic study. Am J Pathol. 1968;53:537–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Ozdöl S, Sahin S, Tokgözoğlu L. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). Int J Dermatol. 2008;47(8):785–89.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Rıza Akyüz MD.

Ethics declarations

Conflicts of interest

A. R. Akyüz, T. Turan, M. E. Erkuş, İ. Gürbak, S. Kul, L. Korkmaz, M. T. Ağaç, and Ş. Çelik declare that there are no actual or potential conflicts of interest in relation to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akyüz, A.R., Turan, T., Erkuş, M.E. et al. Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects. Wien Klin Wochenschr 128 (Suppl 8), 610–613 (2016). https://doi.org/10.1007/s00508-016-0989-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-016-0989-6

Keywords

Navigation